A detailed history of Univest Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Univest Financial Corp holds 29,679 shares of ABT stock, worth $3.5 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
29,679
Previous 2,960 902.67%
Holding current value
$3.5 Million
Previous $307,000 1001.95%
% of portfolio
0.22%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $2.67 Million - $3.16 Million
26,719 Added 902.67%
29,679 $3.38 Million
Q2 2024

Aug 05, 2024

SELL
$100.73 - $112.44 $19,642 - $21,925
-195 Reduced 6.18%
2,960 $307,000
Q1 2024

May 08, 2024

SELL
$109.52 - $120.96 $10,952 - $12,096
-100 Reduced 3.07%
3,155 $358,000
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $8,477 - $10,377
-94 Reduced 2.81%
3,255 $358,000
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $3.12 Million - $3.75 Million
-32,705 Reduced 90.71%
3,349 $324,000
Q2 2023

Aug 07, 2023

BUY
$100.78 - $112.29 $174,651 - $194,598
1,733 Added 5.05%
36,054 $3.93 Million
Q1 2023

May 08, 2023

BUY
$96.86 - $114.01 $100,928 - $118,798
1,042 Added 3.13%
34,321 $3.48 Million
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $1.09 Million - $1.27 Million
11,424 Added 52.27%
33,279 $3.65 Million
Q3 2022

Nov 03, 2022

SELL
$96.76 - $112.03 $1.23 Million - $1.42 Million
-12,678 Reduced 36.71%
21,855 $2.12 Million
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $127,791 - $154,459
1,252 Added 3.76%
34,533 $3.75 Million
Q1 2022

May 05, 2022

BUY
$114.02 - $139.04 $3.62 Million - $4.42 Million
31,765 Added 2095.32%
33,281 $3.94 Million
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $175,143 - $214,453
1,516 New
1,516 $214,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Univest Financial Corp Portfolio

Follow Univest Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Univest Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Univest Financial Corp with notifications on news.